A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam.

Psychopharmacology
Carlo CifaniMaurizio Massi

Abstract

Preclinical models are needed to investigate the neurobiology and psychobiology of binge eating and to identify innovative pharmacotherapeutic strategies. A modification of the model based on the combination of cyclic caloric restrictions and acute stress was developed to further increase its face validity and reliability and, for the first time, to assess its predictive value. Four groups of female rats were employed: group 1 was normally fed and not stressed on the test day (25th); group 2 was fed normally but was exposed to an acute stress on day 25; group 3 was exposed to three cycles (4 days 66% of chow intake + 4 days food ad libitum) of yo-yo dieting but not stressed; and group 4 was exposed to cyclic yo-yo dieting and then stressed. All groups were fed highly palatable food (HPF) for 2 h on days 5-6 and 13-14. Acute stress was elicited by exposing rats to HPF, but preventing them from access to it for 15 min. The combination of cyclic food restriction and stressful exposure to food markedly increased HPF intake. Sibutramine and fluoxetine inhibited food intake in all conditions. Topiramate selectively inhibited compulsive HPF intake in rats submitted to caloric restriction and stress. Midazolam increased HPF intake. Pha...Continue Reading

References

Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Scalliet
Dec 1, 1991·Biological Psychiatry·T E WeltzinW H Kaye
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·S J Cooper, L B Estall
Jan 1, 1989·Annals of the New York Academy of Sciences·G P Smith
Aug 1, 1982·Psychological Medicine·S F Abraham, P J Beumont
May 1, 1994·Journal of Abnormal Psychology·J PolivyA L Beal
Jun 26, 1998·Journal of Reproduction and Fertility·A J LeighC A Wilson
Aug 26, 1998·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·J H Schneiderman
Mar 17, 2000·Journal of Psychosomatic Research·J WardleZ Lipsey
Jan 3, 2001·The International Journal of Eating Disorders·A WatersG Waller
Apr 4, 2001·The International Journal of Eating Disorders·J H CrowtherK L Shepherd
Jul 6, 2001·The International Journal of Eating Disorders·E SticeT Wilson
Feb 13, 2002·The Journal of Clinical Psychiatry·Jose C AppolinarioWalmir Coutinho
Nov 26, 2002·The Journal of Clinical Psychiatry·Lesley M ArnoldPaul E Keck
Aug 5, 2003·The International Journal of Eating Disorders·Mary M HaganKimberly D Oswald
Aug 6, 2003·The International Journal of Eating Disorders·William P CarterHarrison G Pope
Apr 1, 1962·Journal of Comparative and Physiological Psychology·G M STERRITT
Nov 26, 2003·Physiology & Behavior·M LeBlanc, L Thibault
Mar 6, 2004·Eating Behaviors·Einar KjelsåsK Gunnar Götestam
Apr 3, 2004·Current Drug Targets·Jose C Appolinario, Susan L McElroy
Apr 22, 2004·The International Journal of Eating Disorders·Michael Strober
Jul 6, 2004·Physiology & Behavior·Rebecca L Corwin, Ariel Buda-Levin
Jul 30, 2004·The International Journal of Eating Disorders·Lisa M Yacono Freeman, Karen M Gil
Jul 31, 2004·Drug and Alcohol Dependence·Kyle M KampmanCharles P O'Brien
Nov 24, 2004·The Journal of Clinical Psychiatry·Susan L McElroyJames I Hudson
Feb 8, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Cristina De BernardiEugenio Torre
Feb 24, 2006·Neuropharmacology·Timothy A SimeoneH Steve White
Jul 4, 2006·Biological Psychiatry·James I HudsonRonald C Kessler
Oct 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·A C HanssonR Ciccocioppo
Jan 9, 2007·Lancet·Raj S Padwal, Sumit R Majumdar
Jan 30, 2007·Biological Psychiatry·Susan L McElroyUNKNOWN Topiramate Binge Eating Disorder Research Group
Mar 21, 2007·The International Journal of Eating Disorders·Jennifer R ShapiroCynthia M Bulik
Apr 17, 2007·International Review of Neurobiology·H Steve WhiteKaren S Wilcox
May 15, 2007·Physiology & Behavior·A I ArtigaM M Boggiano
Nov 7, 2007·Drug and Alcohol Dependence·Doug Hyun HanPerry F Renshaw
Dec 7, 2007·The American Journal of Psychiatry·Denise E WilfleyUNKNOWN Sibutramine Binge Eating Disorder Research Group
May 13, 2008·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Alessandra Diehl ReisRonaldo Laranjeira
Jul 5, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Paolo LeombruniSecondo Fassino

❮ Previous
Next ❯

Citations

Oct 22, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sunila G NairYavin Shaham
May 10, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Laura PiccoliMauro Corsi
Sep 11, 2009·Addiction Biology·Andrea HeyneJochen Wolffgramm
Sep 22, 2012·Journal of Obesity·Maria Vittoria Micioni Di BonaventuraCarlo Cifani
Feb 3, 2016·Behavioural Processes·Madge Farias FechineRaul Manhães-de-Castro
Oct 24, 2014·Nutrients·Matteo Di SegniRossella Ventura
Sep 1, 2014·Neuroscience and Biobehavioral Reviews·C D'AddarioM Maccarrone
May 10, 2011·Physiology & Behavior·Rebecca L CorwinMary M Boggiano
May 12, 2011·Physiology & Behavior·Sarah L ParylakEric P Zorrilla
May 29, 2014·British Journal of Pharmacology·M A van GestelS K Janhunen
Apr 17, 2013·Addiction Biology·Riccardo DorePietro Cottone
Nov 25, 2014·Journal of the Experimental Analysis of Behavior·Jeffrey S SteinGregory J Madden
May 18, 2016·Physiology & Behavior·Valentina SattaPaola Fadda
Mar 18, 2015·PloS One·Enrico PatronoRossella Ventura
Jun 1, 2012·Obesity Facts·Johannes W de JongRoger A H Adan
Feb 24, 2017·The International Journal of Eating Disorders·Maria Vittoria Micioni Di BonaventuraCarlo Cifani
Jan 13, 2018·Nutrients·Marta G Novelle, Carlos Diéguez
Jun 5, 2019·Journal of Psychopharmacology·Maria Vittoria Micioni Di BonaventuraCarlo Cifani
Oct 8, 2014·Addiction Biology·Elena Martín-GarcíaRafael Maldonado
Oct 9, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Samantha SpierlingEric P Zorrilla
Oct 13, 2019·Genes, Brain, and Behavior·Roberta G AnversaRobyn M Brown
May 1, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Adele RomanoSilvana Gaetani
Aug 24, 2017·The International Journal of Eating Disorders·Maria Vittoria Micioni Di BonaventuraCarlo Cifani
Dec 14, 2018·CNS Drugs·Susan L McElroyFrancisco Romo-Nava
Nov 19, 2020·Nutrients·Emanuela Micioni Di BonaventuraCarlo Cifani
Sep 5, 2020·ACS Chemical Neuroscience·Carlo CifaniMaria Vittoria Micioni Di Bonaventura
Apr 17, 2021·Neuropharmacology·Katherine M SerafineEric P Zorrilla
Jul 29, 2021·Journal of Psychopharmacology·David J Heal, Sharon L Smith
Dec 10, 2019·Physiology & Behavior·Julliet Araújo de SouzaSandra Lopes de Souza
Aug 27, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Emanuela Micioni Di BonaventuraMaria Vittoria Micioni Di Bonaventura
Nov 8, 2021·Neuroscience and Biobehavioral Reviews·Simone RehnCathalijn H C Leenaars

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.